88040994791Infect Control Hosp EpidemiolInfect Control Hosp EpidemiolInfection control and hospital epidemiology0899-823X1559-683424602955418336010.1086/675610NIHMS581209ArticlePoint Prevalence of Klebsiella pneumoniae
Carbapenemase-Producing Enterobacteriaceae in MarylandJohnsonJ. KristiePh.D12WilsonLucy E.MD, ScM3ZhaoLiChengPh.D1RichardsKatherineMPH3ThomKerri A.MD2HarrisAnthony D.MD2the Maryland MDRO Prevention CollaborativeDepartments of Pathology, University of Maryland School of Medicine
Baltimore, Maryland Epidemiology and Public Health, University of Maryland School of Medicine
Baltimore, Maryland Maryland Department of Health and Mental Hygiene, Baltimore, Maryland Corresponding Author: J. Kristie Johnson, Ph.D. Associate Professor,
Departments of Pathology and Epidemiology and Public Health University of Maryland School
of Medicine 22 South Greene Street, Room N2W69 Baltimore, Maryland 21201
jkjohnson@som.umaryland.edu652014420140142015354443445
Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as
significant healthcare-associated multidrug-resistant pathogens across the United
States.1Klebsiella pneumoniae carbapenemase-producing
Enterobacteriaceae (KPCs) are the primary organisms of antibiotic
resistance for this type of infection in the US.2 Bacterial strains that harbor carbapenem resistance genes have shown resistance to all known
first line therapeutic options and the threat of the spread of these organisms is of great
concern to the US healthcare system.3
Colonization and infection with KPCs have been associated with several healthcare-associated
factors, and an increase in associated morbidity and mortality has been documented.4
Despite its notoriety, the true burden of KPCs is unknown. The colonized patient is
an important reservoir of CREs and represents a key to understanding the spread and control of
these organisms. In this study, we determined the colonization prevalence of KPCs in a cohort
of mechanically ventilated patients residing in all healthcare settings (acute and long term
care) by performing a statewide prospective cross-sectional prevalence survey to determine the
burden of KPCs in Maryland.
All healthcare facilities that provide care to mechanically ventilated patients in
Maryland were invited to participate; participation was voluntary. The prevalence survey was
performed during a 12-day period from July-August 2010. Each facility collected peri-anal and
sputum samples from eligible patients. The survey was performed as a public health initiative
and no patient identifying information was collected. Peri-anal cultures were obtained using
Staplex II cotton swabs (Staplex) and sputum cultures were collected during routine
respiratory care. All samples were analyzed for a previous study and frozen at
−70°C.5 The samples were
thawed and the detection of KPCs was performed following the CDC method.6 Susceptibility testing and amplification and
sequencing of blaKPC was performed on all isolates.7,8 Multi-locus sequence typing was
performed on KPC-producing Klebsiella pneumoniae and Escherichia
coli isolates to determine strain relatedness.
Forty (70%) of the 57 eligible healthcare facilities within 5 regions of Maryland
participated in the survey (Figure 1); 30 (67%) of the
eligible acute care facilities and 10 (83%) of the eligible LTC facilities. Among the 40
facilities that participated, five facilities (four acute care and one LTC) did not have an
eligible/ventilated patient during the study period and therefore no specimens were collected.
Characteristics of participating facilities were published previously.5
Among participating facilities, there were 390 patients eligible to be enrolled and
surveillance cultures were obtained from 358 (92%). KPC-producing genes were detected in 22 bacterial
isolates from 20 (6%) patients (5 sputa and 17 peri-anal; Table 1). Two patients had KPCs detected in both the sputum and peri-anal specimen.
KPCs were isolated from patients in 9 (23%) healthcare facilities, 4 acute care and 5 LTC
facilities. Eleven (55%) of the 20 patients resided in a LTC facility. KPCs were found in two
regions of Maryland. Culture detected 15 K. pneumoniae, 6 E.
coli, and 1 Enterobacter cloacae. Of these isolates, 19 harbored
the blaKPC-2 and 3 harbored the
blaKPC-3. Molecular typing revealed three different K.
pneumoniae strains found in 4 acute care and 3 LTC facilities. Of the
K. pneumoniae isolates, 60% (9/15) were ST 258 found in 6 healthcare
facilities (3 acute care and 3 LTC). There were four different E. coli
strains detected in 4 facilities (1 acute care and 3 LTC). Of the E. coli 50%
(3/6) were ST 131 found in 1 acute care and 2 LTC facilities. One facility had KPC producing
K. pneumoniae, E. coli, and E. cloacae
detected harboring either the KPC-2 or KPC-3 gene.
We found that mechanically ventilated patients have a high prevalence of KPCs within
a variety of healthcare facilities in Maryland. We showed that 6% of patients from 40 acute
care and LTC facilities in Maryland were colonized with KPC-producing
Enterobacteriaceae. 55% of the KPCs were found in LTC facilities. KPCs were
found primarily in peri-anal swabs but in three patients, KPCs were only found in the sputum.
These CREs were detected exclusively in the central and national capital regions in Maryland,
which are more populated areas with a higher number of healthcare facilities. Molecular typing
data showed transmission of organisms within and between healthcare facilities.
KPCs are emerging as a serious threat within the US, yet the true burden is unknown.
In 2012, the CDC reported that 4.6% of acute care hospitals reported at least one CRE from
clinical cultures.9 However, previous to this
study, no statewide active surveillance of the true burden of CREs has been reported anywhere
in the nation. Thibodeau et al performed a voluntary, statewide, paper-based survey on
clinical cultures in Massachusetts hospitals and found that nearly half of all Massachusetts
hospitals detected a CRE in 2010 and that these CREs were more often detected in teaching
hospitals than non-teaching hospitals.10
However, the use of clinical cultures only as well as the use of differing definitions of CREs
make it difficult to interpret the Massachusetts results. In our study we collected
surveillance peri-anal and sputum cultures and used enrichment techniques to determine the
prevalence of KPCs utilizing identical laboratory methods and definitions for each facility.
We also performed molecular typing on bacterial strains harboring KPCs and revealed a dominant
strain type for both K. pneumoniae and E. coli.
This study has several limitations. We could not rule out response bias since only
70% of the healthcare facilities participated in survey. At the time of this study, the
importance of urine as a specimen to detect CREs was unknown therefore we might have missed
patients colonized with KPCs. In addition, this point prevalence was limited to patients
receiving mechanical ventilation, who are known to have higher rates of colonization, and
therefore the KPC prevalence cannot be generalized to other patients populations.
In conclusion, this is the first study to our knowledge to examine the colonization
rate of KPCs in a cohort of mechanically ventilated patients residing in both acute and long
term care healthcare facilities in one state within the United States.
Acknowledgements
Financial support: This work was supported by the Centers for Disease Control
and Prevention, American Recovery and Reinvestment Act Epidemiology and Laboratory Capacity
for Infectious Diseases (ELC), Healthcare-Associated Infections–Building and
Sustaining State Programs to Prevent Healthcare-Associated Infections funding opportunity
CI07-70402ARRA09. J.K.J is funded by the National Institutes of health (K12RR023250). K.A.T.
is supported by the National Institutes of Health (K23AI082450-01A1). A.D.H. is supported by
the National Institutes of Health (K24AI079040, R01AI60859-01A1, and 2R01AI060859)
Potential Conflicts of Interest: All authors: No reported
conflicts.
Part of this work has been presented previously at the 52th Annual
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco,
CA, September 2012.
LandmanDBabuEShahNTransmission of carbapenem-resistant pathogens in new york city hospitals:
Progress and frustrationJ Antimicrob Chemother201267614271431doi: 10.1093/jac/dks06322378678GuptaNLimabagoBPatelJKallenACarbapenem-Resistant Enterobacteriaceae: Epidemiology and
PreventionClinical Infectious Disease20115316067QueenanABKarenCarbapenemases: The versatile beta-lactamasesClin Microbiol Rev200720344058table of contents. doi: 10.1128/CMR.00001-0717630334PatelGHuprikarSFactorSJenkinsSCalfeeDOutcomes of carbapenem-resistant klebsiella pneumoniae infection and the
impact of antimicrobial and adjunctive therapiesInfection control and hospital epidemiology2008291210991106doi: 10.1086/59241218973455ThomKerri MaragakisRichardsLisaJohnsonKatieRoupJKLawsonBrendaHarrisPatriciaFussAnthonyPassElizabethBlytheMargaretPerencevichDavidEli WilsonLucyAssessing the burden of acinetobacter baumannii in maryland: A statewide
cross-sectional period prevalence surveyInfection control and hospital epidemiology2012339883888doi: 10.1086/66737622869261CalfeeDJStephenUse of active surveillance cultures to detect asymptomatic colonization
with carbapenem-resistant klebsiella pneumoniae in intensive care unit
patientsInfection control and hospital epidemiology20082910966968doi: 10.1086/59066118754738Clinical and Laboratory Standards InstitutePerformance standards for antimicrobial disk susceptibility testing; twenty
-second informational supplement2012RasheedBiddleJKAndersonJamesWasherKarenChenowethLarainePerrinCarolNewtonJohnPatelDuaneJeanDetection of the klebsiella pneumoniae carbapenemase type 2
carbapenem-hydrolyzing enzyme in clinical isolates of citrobacter freundii and K.
oxytoca carrying a common plasmidJ Clin Microbiol200846620662069doi: 10.1128/JCM.02038-0718385437Vital signs: Carbapenem-resistant enterobacteriaceaeMorb Mortal Weekly Rep2013629165170ThibodeauDuncanEvangelineSnydmanRobertBolstorffDavidVostokBarbaraBartonJohannaDemariaKerriAlfredCarbapenem-resistant enterobacteriaceae: A statewide survey of detection in
massachusetts hospitalsInfection control and hospital epidemiology2012339954956doi: 10.1086/66737722869273
Seventy (70%) of Maryland Healthcare centers with mechanically ventilated patients
participated in the study. KPC-producing Enterobacteriaceae were found in
23% of facilities, which were located in 2 major regions of Maryland.
Characterization of Enterobacteriaceae-producing Klebsiella
pneumoniae carbapeneamase.